1. Home
  2. TRVI vs NFGC Comparison

TRVI vs NFGC Comparison

Compare TRVI & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • NFGC
  • Stock Information
  • Founded
  • TRVI 2011
  • NFGC 2016
  • Country
  • TRVI United States
  • NFGC Canada
  • Employees
  • TRVI N/A
  • NFGC N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • NFGC Precious Metals
  • Sector
  • TRVI Health Care
  • NFGC Basic Materials
  • Exchange
  • TRVI Nasdaq
  • NFGC Nasdaq
  • Market Cap
  • TRVI 341.4M
  • NFGC 352.1M
  • IPO Year
  • TRVI 2019
  • NFGC N/A
  • Fundamental
  • Price
  • TRVI $3.76
  • NFGC $1.71
  • Analyst Decision
  • TRVI Strong Buy
  • NFGC Strong Buy
  • Analyst Count
  • TRVI 8
  • NFGC 1
  • Target Price
  • TRVI $9.31
  • NFGC $9.00
  • AVG Volume (30 Days)
  • TRVI 659.4K
  • NFGC 379.9K
  • Earning Date
  • TRVI 11-06-2024
  • NFGC 11-12-2024
  • Dividend Yield
  • TRVI N/A
  • NFGC N/A
  • EPS Growth
  • TRVI N/A
  • NFGC N/A
  • EPS
  • TRVI N/A
  • NFGC N/A
  • Revenue
  • TRVI N/A
  • NFGC N/A
  • Revenue This Year
  • TRVI N/A
  • NFGC N/A
  • Revenue Next Year
  • TRVI N/A
  • NFGC N/A
  • P/E Ratio
  • TRVI N/A
  • NFGC N/A
  • Revenue Growth
  • TRVI N/A
  • NFGC N/A
  • 52 Week Low
  • TRVI $1.27
  • NFGC $1.51
  • 52 Week High
  • TRVI $4.68
  • NFGC $4.15
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 48.03
  • NFGC 45.16
  • Support Level
  • TRVI $3.63
  • NFGC $1.69
  • Resistance Level
  • TRVI $4.06
  • NFGC $1.97
  • Average True Range (ATR)
  • TRVI 0.30
  • NFGC 0.11
  • MACD
  • TRVI -0.09
  • NFGC -0.00
  • Stochastic Oscillator
  • TRVI 12.21
  • NFGC 25.71

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About NFGC New Found Gold Corp

New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).

Share on Social Networks: